Overview of the role and content of PET-CT

PET-CT (positron emission computed tomography) is an advanced medical imaging technology that combines PET (functional metabolic imaging) and CT (anatomical structure imaging). It is mainly used for early diagnosis, staging, efficacy evaluation and recurrence monitoring of diseases. Its core functions include:Accurate diagnosis of tumors(such as positioning, benign and malignant identification),cardiovascular disease assessment(such as myocardial viability testing),Neurological disease research(such as Alzheimer's disease diagnosis), etc. In terms of primary and secondary structure, tumor applications are the core, followed by cardiovascular and neurological fields, and finally other rare disease research.

Tumor diagnosis and staging: core applications of PET-CT

The role of PET-CT in the field of cancer is irreplaceable. By injecting radioactive tracers (such as 18F-FDG), it can clearly display the metabolic activity of tumors, help doctors distinguish between benign and malignant tumors, and accurately locate primary tumors and metastases. For example, patients with lung cancer can use PET-CT to confirm tumor staging and avoid unnecessary punctures or surgeries. In addition, it is also crucial for the evaluation of the efficacy of lymphoma, breast cancer, etc. It can detect signs of treatment ineffectiveness or recurrence early and provide a basis for adjusting the plan.

Cardiovascular and Nervous Systems: Breakthroughs in Functional Imaging

In the cardiovascular field, PET-CT can evaluate myocardial blood perfusion and metabolism, determine whether the myocardium is viable, and provide key reference for bypass or stent surgery. In terms of the nervous system, it can display changes in brain glucose metabolism and assist in the diagnosis of Alzheimer's disease and the location of epileptic focus. For example, amyloid PET imaging has become one of the gold standards for dementia classification. These applications make up for the shortcomings of traditional imaging, but they need to be combined with other clinical examinations for comprehensive judgment.

Technical advantages and limitations

The advantage of PET-CT is the "one-stop" acquisition of functional and anatomical information and its high sensitivity. However, it has limitations such as radiation exposure (the pros and cons need to be weighed) and high cost (about 10,000 yuan for a single examination). In addition, certain inflammatory or physiological uptake may cause false positives and require interpretation by an experienced physician. At present, domestic equipment such as United Imaging's uMI series has gradually broken the import monopoly (such as Siemens Biograph, GE Discovery) and reduced medical costs.

Summary: Clinical value and future of PET-CT

With its multi-modal imaging technology, PET-CT has become an important tool for modern precision medicine, especially in the field of oncology. With the development of tracers (such as PSMA for prostate cancer) and equipment upgrades, its application scope will be further expanded. However, it should be noted that it is not a panacea. Only by rationally selecting indications and standardizing operating procedures can its value be maximized. In the future, artificial intelligence-assisted analysis and lower-dose technology may become the direction of development.

Quote sources:
1. "Nuclear Medicine and Molecular Imaging" (Editor-in-Chief: Tian Jiahe)
2. "PET-CT Clinical Operation Guidelines" by the Nuclear Medicine Branch of the Chinese Medical Association
3. Technical description of products on the official websites of Siemens, GE Healthcare, and United Imaging Healthcare